Paid Clinical Trials Nashville

Discover 1,262 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,262

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Nashville TN, Birmingham AL, Chamblee GA, Atlanta GAshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Observational StudyPhysiological Brain Atlas Development

Recruiting

Sponsor:

Vanderbilt University Medical Center

Location:

Nashville TN

Code:

NCT00575081

Conditions

Parkinson's Disease

Obsessive Compulsive Disorder

Dystonia

Essential Tremor

Epilepsy

Eligibility Criteria

Sex: All

Age: 6 - 70+

Healthy Volunteers: Not accepted

Interventions

Stereotactic brain procedures

Observational StudyRegistry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

Recruiting

Sponsor:

Axogen Corporation

Location:

Nashville TN, Lexington KY, Germantown TN, Atlanta GAshow 33 more

Code:

NCT01526681

Conditions

Peripheral Nerve Injuries

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Processed Human Nerve Graft

Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.

Autogenous Nerve Graft

Nerve Tube Conduit

Autologous Breast Reconstruction with Neurotization

Neurophysiology BiomarkersNeurophysiology Biomarkers of Cognitive Impairment Associated with Deep Brain Stimulation

Recruiting

Sponsor:

Vanderbilt University Medical Center

Location:

Nashville TN

Code:

NCT05933681

Conditions

Parkinson Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Neural recordings and stimulation

BT8009Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Recruiting

PHASE1

PHASE2

Sponsor:

BicycleTx Limited

Location:

Nashville TN, Louisville KY, Lafayette IN, Cleveland OHshow 10 more

Code:

NCT04561362

Conditions

Urinary Bladder Neoplasm

Triple Negative Breast Neoplasms

Hormone Receptor Positive, HER2-negative Neoplasms

Hormone Receptor Positive, HER2-low Neoplasms

Breast Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BT8009

Pembrolizumab

P-CD19CD20-ALLO1P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

Recruiting

PHASE1

Sponsor:

Poseida Therapeutics, Inc.

Location:

Nashville TN, Cincinnati OH, Greenville SC, Chapel Hill NCshow 5 more

Code:

NCT06014762

Conditions

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

High-grade B-cell Lymphoma

Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Transformed Follicular Lymphoma (tFL)

Follicular Lymphoma Grade 3B

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

P-CD19CD20-ALLO1

Rimiducid

Observational StudyText-messaging Intervention to Support Parents After Their Child's Psychiatric Emergency

Recruiting

Sponsor:

Vanderbilt University Medical Center

Location:

Nashville TN

Code:

NCT06456762

Conditions

Parents

Self Efficacy

Mental Health Literacy

Psychiatric Emergency

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

iPEACE: Intervention for Parent Education about Care after the ED

Text Messaging Reminders Only

Observational StudyContinuous Monitoring and Control of Hypoglycemia

Recruiting

Sponsor:

DexCom, Inc.

Location:

Nashville TN, Atlanta GA, Asheville NC, Skokie ILshow 20 more

Code:

NCT03340831

Conditions

Diabetes

Eligibility Criteria

Sex: All

Age: 2+

Healthy Volunteers: Not accepted

Interventions

Continuous Glucose Monitoring (CGM)

BIIB091 & DRFA Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

Recruiting

PHASE2

Sponsor:

Biogen

Location:

Nashville TN, Cordova TN, Cincinnati OH, Saint Louis MOshow 19 more

Code:

NCT05798520

Conditions

Relapsing Forms of Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

BIIB091

DRF

Placebo

SAcituzumab Govitecan & TrastuzumabA Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)

Recruiting

PHASE2

Sponsor:

Adrienne G. Waks

Location:

Nashville TN, Boston MA, South Weymouth MA

Code:

NCT06100874

Conditions

Her 2 Positive Breast Cancer

Breast Cancer Female

Breast Cancer Metastatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab Govitecan

Trastuzumab

Trastuzumab and Hyaluronidase-oysk

GIM-122Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

Recruiting

PHASE1

PHASE2

Sponsor:

Georgiamune Inc

Location:

Nashville TN, Louisville KY, Richmond VA, Dallas TXshow 5 more

Code:

NCT06028074

Conditions

Advanced Solid Malignancies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

GIM122